20Slash20 Inc., the company behind The Eye Drink, announced it will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for Sept. 9–10, 2026, in New York City. CEO Dr. Roger Wu is set to deliver an investor presentation on Sept. 9 at 9:35 a.m. ET at The Westin New York Grand Central, followed by one-on-one meetings with investors. The conference will bring together growth companies, investors, and industry professionals across life sciences and other emerging sectors, providing a platform for 20Slash20 to showcase its innovative product.
The Eye Drink is positioned as the world’s first ready-to-drink functional beverage formulated specifically for individuals who spend extended hours on cellphones or computers. The drink uses science-backed ingredients to support eye health and protect against screen-induced eye problems. In an era where digital device usage is pervasive, the product addresses a growing concern: the strain that prolonged screen time places on vision. According to the company, The Eye Drink offers a convenient and tasty solution, making it easier for consumers to incorporate eye health into their daily routines.
The significance of this presentation lies in the increasing awareness of digital eye strain and the demand for preventive health products. As remote work and digital entertainment continue to dominate lifestyles, the market for functional beverages targeting specific health needs is expanding. 20Slash20 aims to capitalize on this trend by offering a product that combines convenience with a health benefit. The company’s participation in this conference will likely attract attention from investors looking for opportunities in the health and wellness sector, particularly those focused on innovative consumer products.
The conference serves as a vital networking opportunity, allowing 20Slash20 to connect with potential partners and investors who are interested in disruptive growth and life sciences. For a company like 20Slash20, which is still establishing its brand, such exposure is crucial for gaining visibility and credibility in a competitive market. The presentation will provide a detailed overview of the company’s vision, product development, and market strategy, offering investors insight into its growth potential.
In a world where screen time is unavoidable, The Eye Drink represents a proactive approach to eye care. Rather than waiting for problems to arise, the beverage offers a preventive measure that fits easily into modern lifestyles. This approach aligns with broader trends in consumer health, where individuals are increasingly seeking products that support overall well-being without major lifestyle changes. By positioning itself at the intersection of technology and health, 20Slash20 is addressing a niche that is likely to grow as digital device usage continues to rise.
The company’s participation in the Moody Capital Solutions conference is a strategic move to highlight its unique value proposition. As the conference focuses on disruptive growth and life sciences, it provides an ideal setting for 20Slash20 to demonstrate how its product breaks new ground in the beverage industry. With the support of InvestorWire, a specialized communications platform, the company is also ensuring that its message reaches a wide audience of investors and consumers.
For more information on the conference or to view the full press release, visit https://ibn.fm/tm2lT.
